12:00 AM
Jul 09, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Lucanthone: Phase II started

Spectrum began a double-blind, international Phase II trial to compare oral 10-15 mg/kg/day lucanthone plus temozolomide and radiation vs. placebo plus temozolomide and radiation in about 140 patients. Following the...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >